Metabolic effects of pioglitazone and rosigli-tazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled parallel-group trial - Derosa, G; Cicero, AF; Gaddi, A; Ragonesi, PD; Fogari, E; Bertone, G (Clin Ther., 2004)
et al.